New hope for hip fracture patients: could a simple pill combo stop deadly heart attacks?
NCT ID NCT07228663
Summary
This study is testing if a combination of two common blood-thinning medications (rivaroxaban and aspirin) can better prevent heart attacks and blood clots in patients who have had hip fracture surgery and show signs of heart injury. It will involve 100 patients aged 45 and older. The goal is to see if a larger future trial is feasible and to gather early information on whether this approach is safe and effective compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM (VTE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Humanitas Research Hospital
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Juravinski Hospital
Hamilton, Ontario, L8V 1C3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St.Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.